Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice

Journal of Clinical Investigation

Volumn 117, Issue 10, 2007, Pages 2825-2833

  Diwan, Abhinav ^a   Krenz, Maike ^a   Syed, Faisal M ^a   Wansapura, Janaka ^b   Ren, Xiaoping ^a   Koesters, Andrew G ^a   Li, Hairong ^a   Kirshenbaum, Lorrie A ^c   Hahn, Harvey S ^d   Robbins, Jeffrey ^a   Jones, W Keith ^a   Dorn II, Gerald W ^a,e  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^d Kettering Memorial Hospital   (United States)

^e Molecular Cardiovascular Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BNIP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE REMODELING; ISCHEMIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; MITOCHONDRIAL PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; VENTRICULAR REMODELING;

EID: 34948816749     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32490     Document Type: Article

References (78)

1. Zheng, Z.J., Croft, J.B., Giles, W.H., and Mensah, G.A. 2001. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 104:2158-2163.
2. Thom, T., et al. 2006. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 113:e85-e151.
3. Gibson, C.M. 2004. NRMI and current treatment patterns for ST-elevation myocardial infarction. Am. Heart J. 148:S29-S33.
4. Kober, L., et al. 1995. A clinical trial of the angiotensin-converting- enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N. Engl. J. Med. 333:1670-1676.
5. Antman, E.M., et al. 2004. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 110:588-636.
6. Pfeffer, M.A., and Braunwald, E. 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 81:1161-1172.
7. Ratcliffe, M.B. 2002. Non-ischemic infarct extension: A new type of infarct enlargement and a potential therapeutic target. J. Am. Coll. Cardiol. 40:1168-1171.
8. Pimentel, D.R., et al. 2001. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ. Res. 89:453-460.
9. Jackson, B.M., et al. 2002. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J. Am. Coll. Cardiol. 40:1160-1167.
10. Kelley, S.T., et al. 1999. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation. 99:135-142.
11. Blom, A.S., et al. 2005. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation. 112:1274-1283.
12. Olivetti, G., et al. 1997. Apoptosis in the failing human heart. N. Engl. J. Med. 336:1131-1141.
13. Saraste, A., et al. 1997. Apoptosis in human acute myocardial infarction. Circulation. 95:320-323.
14. Wilson, E.M., et al. 2003. Region- and type-specific induction of matrix metalloproteinases in postmyocardial infarction remodeling. Circulation. 107:2857-2863.
15. Sadoshima, J., and Izumo, S. 1993. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12:1681-1692.
16. Dorn, G.W. 2005. Physiologic growth and pathologic genes in cardiac development and cardiomyopathy. Trends Cardiovasc. Med. 15:185-189.
17. Dorn, G.W., and Force, T. 2005. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 115:527-537. doi:10.1172/JCI200524178.
18. Yaoita, H., Ogawa, K., Maehara, K., and Maruyama, Y. 1998. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:276-281.
19. Chandrashekhar, Y., Sen, S., Anway, R., Shuros, A., and Anand, I. 2004. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J. Am. Coll. Cardiol. 43:295-301.
20. Boyd, J.M., et al. 1994. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell. 79:341-351.
21. Bruick, R.K. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. U. S. A. 97:9082-9087.
22. Galvez, A.S., et al. 2006. Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J. Biol. Chem. 281:1442-1448.
23. Regula, K.M., Ens, K., and Kirshenbaum, L.A. 2002. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ. Res. 91:226-231.
24. Sowter, H.M., Ratcliffe, P.J., Watson, P., Greenberg, A.H., and Harris, A.L. 2001. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:6669-6673.
25. Hamacher-Brady, A., et al. 2007. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 14:146-157.
26. Kubasiak, L.A., Hernandez, O.M., Bishopric, N.H., and Webster, K.A. 2002. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. U. S. A. 99:12825-12830.
27. Yasuda, M., Theodorakis, P., Subramanian, T., and Chinnadurai, G. 1998. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J. Biol. Chem. 273:12415-12421.
28. Bouillet, P., et al. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1735-1738.
29. Bouillet, P., et al. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:922-926.
30. Ranger, A.M., et al. 2003. Bad-deficient mice develop diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 100:9324-9329.
31. -/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proc. Natl. Acad. Sci. U. S. A. 104:6794-6799.
32. Bajaj, A.K., et al. 1989. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation. Circulation. 79:645-656.
33. Entman, M.L., et al. 1991. Inflammation in the course of early myocardial ischemia. FASEB J. 5:2529-2537.
34. Iversen, P.O., and Sorensen, D.R. 2007. A murine model for studying hematopoiesis and immunity in heart failure. Methods Mol. Biol. 360:269-275.
35. van Amerongen, M.J., Harmsen, M.C., van Rooijen, N., Petersen, A.H., and van Luyn, M.J. 2007. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 170:818-829.
36. van Beusekom, H.M., et al. 1993. Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J. Am. Coll. Cardiol. 21:45-54.
37. Fieno, D.S., et al. 2004. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J. Am. Coll. Cardiol. 43:2124-2131.
38. Cheng, A., et al. 2006. Passive ventricular constraint prevents transmural shear strain progression in left ventricle remodeling. Circulation. 114:I79-I86.
39. Sam, F., et al. 2000. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am. J. Physiol. Heart Circ. Physiol 279:H422-H428.
40. Palojoki, E., et al. 2001. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 280:H2726-H2731.
41. Guo, K., et al. 2001. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ. 8:367-376.
42. Zhang, S., et al. 2007. Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res. 1138:221-230.
43. Leo, C., Horn, L.C., and Hockel, M. 2006. Hypoxia and expression of the proapoptotic regulator BNIP3 in cervical cancer. Int. J. Gynecol.Cancer. 16:1314-1320.
44. Syed, F.M., et al. 2005. Proapoptotic effects of caspase-1/interleukin- converting enzyme dominate in myocardial ischemia. Circ. Res. 96:1103-1109.
45. Yussman, M.G., et al. 2002. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat. Med. 8:725-730.
46. Galvez, A.S., et al. 2007. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ. Res. 100:1071-1078.
47. Wencker, D., et al. 2003. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111:1497-1504. doi:10.1172/JCI200317664.
48. Chandrashekhar, Y. 2005. Role of apoptosis in ventricular remodeling. Curr. Heart Fail. Rep. 2:18-22.
49. Bouillet, P., and Strasser, A. 2002. BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 115:1567-1574.
50. Kubli, D.A., Ycaza, J.E., and Gustafsson, A.B. 2007. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem. J. 405:407-415.
51. Chen, G., et al. 1997. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186:1975-1983.
52. Chen, G., et al. 1999. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J. Biol. Chem. 274:7-10.
53. Graham, R.M., et al. 2004. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J. Exp. Biol. 207:3189-3200.
54. Vande, V.C., et al. 2000. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20:5454-5468.
55. Webster, K.A., Graham, R.M., and Bishopric, N.H. 2005. BNip3 and signal-specific programmed death in the heart. J. Mol. Cell. Cardiol. 38:35-45.
56. Fliss, H., and Gattinger, D. 1996. Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 79:949-956.
57. Gottlieb, R.A., Burleson, K.O., Kloner, R.A., Babior, B.M., and Engler, R.L. 1994. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94:1621-1628.
58. Jeremias, I., et al. 2000. Involvement of CD95/ Apo1/Fas in cell death after myocardial ischemia. Circulation. 102:915-920.
59. Lee, P., et al. 2003. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am. J. Physiol. Heart Circ. Physiol. 284:H456-H463.
60. Yin, X.M. 2000. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res. 10:161-167.
61. Foo, R.S.-Y, Mani, K., and Kitsis, R.N. 2005. Death begets failure in the heart. J. Clin. Invest. 115:565-571. doi:10.1172/JCI200524569.
62. Baetz, D., et al. 2005. Nuclear factor-kappaB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation. 112:3777-3785.
63. Brocheriou, V., et al. 2000. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J. Gene Med. 2:326-333.
64. Chen, Z., Chua, C.C., Ho, Y.S., Hamdy, R.C., and Chua, B.H. 2001. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 280:H2313-H2320.
65. Cohn, J.N., Ferrari, R., and Sharpe, N. 2000. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 35:569-582.
66. Yu, C.M., et al. 2005. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 112:1580-1586.
67. Muller-Ehmsen, J., et al. 2002. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 105:1720-1726.
68. Anversa, P., et al. 2007. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells. 25:589-601.
69. Syed, F., Diwan, A., and Hahn, H.S. 2005. Murine echocardiography: a practical approach for phenotyping genetically manipulated and surgically modeled mice. J. Am. Soc. Echocardiogr. 18:982-990.
70. Syed, F., et al. 2004. Physiological growth synergizes with pathological genes in experimental cardiomyopathy. Circ. Res. 95:1200-1206.
71. Guo, Y., et al. 1998. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am. J. Physiol. 275:H1375-H1387.
72. Ren, X., Wang, Y., and Jones, W.K. 2004. TNF-alpha is required for late ischemic preconditioning but not for remote preconditioning of trauma. J. Surg. Res. 121:120-129.
73. Yang, Z., Berr, S.S., Gilson, W.D., Toufektsian, M.C., and French, B.A. 2004. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation. 109:1161-1167.
74. Weiss, C.R., et al. 2003. Stunned, infarcted, and normal myocardium in dogs: simultaneous differentiation by using gadolinium-enhanced cine MR imaging with magnetization transfer contrast. Radiology. 226:723-730.
75. Lee, S.S., et al. 2003. MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model. Radiology. 226:739-747.
76. Barkhausen, J., Ebert, W., Debatin, J.F., and Weinmann, H.J. 2002. Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits. J. Am. Coll. Cardiol. 39:1392-1398.
77. Milei, J., and Storino, R. 1986. Early myocardial infarction. A feasible histologic diagnostic procedure. Jpn. Heart J. 27:307-319.
78. Sanbe, A., et al. 2003. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ. Res. 92:609-616.